Legal Team Sues Drug Maker Hoffmann-La Roche Limited Over Popular Acne Medicine
According to the Canadian Dermatology Association, acne affects nearly 20% or 5.6 million Canadians. More than 80% of acne sufferers are between the ages of 12 and 24.
The lawyers say the Twamley case is being put forward as the face of the Accutane lawsuit and a test case for more than a dozen similar cases they are preparing to file against the company. Legate says, "This case will cast a light on the problem and we expect many other victims to come forward."
The lawsuit claims that that Hoffmann-La Roche was negligent because it failed to warn the public that the drug could cause inflammatory bowel disease.
Williams adds, "Accutane affects each person differently, so the harm and damages they suffer varies widely. By choosing to bring a mass tort, we believe the victims are well served as their medical damages can be properly assessed on an individual basis."Legate & Associates is a London, Ontario-based personal injury law firm that serves southwestern Ontario. Harrison Pensa is a full-service, 55-lawyer firm servicing southwestern, Ont., with offices in London and Toronto. Download videos for broadcast purposes: Lawsuit Overview | MP4 | 332MB https://www.dropbox.com/s/t97qq7h6n18okqp/Overview_XBGM.mp4 Jennifer's Story | MP4 | 415MB https://www.dropbox.com/s/62ez9waitmclbq9/JennifersStory_XBGM.mp4 Legal Perspective | MP4 | 466MB https://www.dropbox.com/s/kr8vjlwyfs0idlh/Lawyers_XBGM.mp4 SOURCE HARRISON PENSA LLP Video with caption: "Legate & Associates and Harrison Pensa launch mass tort over acne drug Accutane". Video available at: http://stream1.newswire.ca/cgi-bin/playback.cgi?file=20130204_C2670_VIDEO_EN_23250.mp4&posterurl=http://photos.newswire.ca/images/20130204_C2670_PHOTO_EN_23250.jpg&clientName=MIddlemiss%20Publishing%20Corporation&caption=Legate%20%26%20Associates%20and%20Harrison%20Pensa%20launch%20mass%20tort%20over%20acne%20drug%20Accutane&title=MIDDLEMISS%20PUBLISHING%20CORPORATION%20%2D%20Legal%20team%20sues%20drug%20maker%20Hoffmann%2DLa%20Roche%20Limited%20over%20popular%20acne%20medicine&headline=Legal%20team%20sues%20drug%20maker%20Hoffmann%2DLa%20Roche%20Limited%20over%20popular%20acne%20medicine
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV